ANIX
Anixa Biosciences Inc
3.00$
+6.5%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -0.6% | -4.0% | -5.9% | -5.7% | -12.4% | -10.2% | +4.0% | -8.9% | -5.3% | -2.4% | +1.4% | |
| – | -0.5% | -4.0% | -6.4% | -5.8% | -12.5% | -10.3% | +4.1% | -9.0% | -5.3% | -2.4% | +1.5% | |
| – | +9.1% | -0.3% | +23.1% | +3.8% | -17.2% | +81.4% | -21.7% | -16.8% | +24.4% | -4.5% | -5.3% | |
| – | -0.2% | -2.3% | -10.7% | -4.0% | -13.4% | -9.6% | +2.8% | -5.3% | -6.4% | -3.6% | +1.3% | |
| – | +44.8% | -44.2% | +88.1% | -57.8% | -100.0% | – | – | – | – | – | – | |
| – | -17.8% | +0.3% | +25.0% | +21.9% | -18.9% | -5.6% | +8.2% | -4.9% | -34.9% | +18.3% | +14.1% | |
| – | -18.1% | +1.3% | +19.2% | +24.8% | -20.0% | -5.6% | +9.5% | -4.8% | -37.2% | +21.4% | +16.3% | |
| – | +3.8% | +3.7% | -57.1% | +20.8% | +24.1% | +2.8% | +5.4% | +5.1% | +2.4% | +4.8% | +4.5% | |
| – | +76.7% | -40.9% | +40.5% | +73.8% | +14.3% | -52.7% | -2.8% | -40.2% | -10.3% | +70.3% | +11.9% | |
| – | +1.1% | -4.0% | -7.8% | -8.1% | -10.7% | -10.0% | +3.3% | -8.6% | -0.6% | -4.0% | 0.0% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +1.2% | +1.5% | +0.4% | -0.5% | +0.9% | +0.0% | +0.9% | -0.1% | +2.4% | +1.1% | +1.8% |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.